Jonathan Slonin

2021

In 2021, Jonathan Slonin earned a total compensation of $2.1M as Chief Clinical Officer at Pacira Pharmaceuticals.

Compensation breakdown

Bonus$212,900
Non-Equity Incentive Plan$145,602
Option Awards$639,479
Salary$426,193
Stock Awards$667,624
Other$30,557
Total$2,122,355

Slonin received $667.6K in stock awards, accounting for 31% of the total pay in 2021.

Slonin also received $212.9K in bonus, $145.6K in non-equity incentive plan, $639.5K in option awards, $426.2K in salary and $30.6K in other compensation.

Rankings

In 2021, Jonathan Slonin's compensation ranked 5,828th out of 12,406 executives tracked by ExecPay. In other words, Slonin earned more than 53.0% of executives.

ClassificationRankingPercentile
All
5,828
out of 12,406
53rd
Division
Manufacturing
2,466
out of 5,494
55th
Major group
Chemicals And Allied Products
1,068
out of 2,369
55th
Industry group
Drugs
950
out of 2,090
55th
Industry
Pharmaceutical Preparations
680
out of 1,537
56th

Pay ratio

Jonathan Slonin's Pay$2,122,355
Median Employee's Pay$199,797
Pay Ratio

11

to 1

In 2021, the annual total compensation of Jonathan Slonin was $2,122,355.

The annual total compensation of the median employee at Pacira Pharmaceuticals was $199,797.

The ratio of Jonathan Slonin's pay to the pay of median employee was therefore 11 to one.

Source: SEC filing on April 22, 2022.

Slonin's colleagues

We found four more compensation records of executives who worked with Jonathan Slonin at Pacira Pharmaceuticals in 2021.

2021

David Stack

Pacira Pharmaceuticals

Chief Executive Officer

2021

Roy Winston

Pacira Pharmaceuticals

Chief Medical Officer

2021

Max Reinhardt

Pacira Pharmaceuticals

President, Rest of World

2021

Charles Reinhart

Pacira Pharmaceuticals

Chief Financial Officer

News

You may also like